Label-free Quantitative Proteomic Analysis of Cerebrospinal Fluid and Serum in Patients With Relapse-Remitting Multiple Sclerosis

Background: The lack of effective serum and cerebrospinal fluid (CSF) biomarkers remains a barrier to early diagnosis and treatment of multiple sclerosis (MS). The study is to identify the diagnostic biomarkers of serum and CSF in patients who suffered MS.Methods: At first, we performed differential...

Full description

Bibliographic Details

Published in:	Frontiers in Genetics
Main Authors:	Haijie Liu, Ziwen Wang, He Li, Meijie Li, Bo Han, Yuan Qi, Huailu Wang, Juan Gao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Subjects:	biomarker cerebrospinal fluid diagnosis label free proteomics relapse-remitting multiple sclerosis serum
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.892491/full